ADAGENE INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.61 USD | +2.35% |
|
+17.04% | +35.14% |
| Mar. 29 | Adagene Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 29 | Adagene Inc. Announces Board Changes | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 351.6 | 57.54 | 84.66 | 112.6 | - | - |
| Enterprise Value (EV) 1 | 184.7 | -58.46 | -3.335 | 20.78 | 89.77 | 36.06 |
| P/E ratio | -5.53 x | -0.9 x | - | -2.9 x | -1.56 x | -2.01 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 34.6 x | 6.19 x | 4.67 x | - | - | 5.7 x |
| EV / Revenue | 18.2 x | -6.29 x | -0.18 x | - | - | 1.83 x |
| EV / EBITDA | -2.59 x | 0.71 x | - | -0.41 x | -1.24 x | -0.64 x |
| EV / FCF | -4,021,649 x | 1,185,688 x | - | - | - | - |
| FCF Yield | -0% | 0% | - | - | - | - |
| Price to Book | 2.81 x | 0.87 x | 1.28 x | 2.22 x | -51 x | 3.92 x |
| Nbr of stocks (in thousands) | 43,577 | 43,423 | 43,835 | 44,157 | - | - |
| Reference price 2 | 8.068 | 1.325 | 1.931 | 2.550 | 2.550 | 2.550 |
| Announcement Date | 3/31/22 | 3/28/23 | 3/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.48 | 0.7009 | 10.18 | 9.293 | 18.11 | - | - | 19.75 |
| EBITDA 1 | - | -32.16 | -71.24 | -82.77 | - | -50.9 | -72.49 | -56.14 |
| EBIT 1 | - | -43.15 | -72.36 | -83.92 | -23.72 | -50.53 | -82.61 | -83.86 |
| Operating Margin | - | -6,156.52% | -711.18% | -903.08% | -130.97% | - | - | -424.71% |
| Earnings before Tax (EBT) 1 | - | - | -71.48 | -79.51 | - | -49.05 | -91.59 | -110.4 |
| Net income 1 | - | - | -73.18 | -79.97 | -18.95 | -49.05 | -91.59 | -110.4 |
| Net margin | - | - | -719.18% | -860.59% | -104.61% | - | - | -559% |
| EPS 2 | -1.100 | - | -1.460 | -1.480 | - | -0.8800 | -1.630 | -1.270 |
| Free Cash Flow | - | -29.46 | -45.92 | -49.3 | - | - | - | - |
| FCF margin | - | -4,203.81% | -451.34% | -530.55% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 9/22/20 | 3/31/21 | 3/31/22 | 3/28/23 | 3/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.359 | 4.41 | 4.41 | 8.816 | 3.923 | 5.37 | 17.3 |
| EBITDA | - | - | - | - | - | - | - |
| EBIT 1 | -37.5 | -17.43 | -17.43 | -34.86 | -48.07 | -35.85 | - |
| Operating Margin | -2,759.99% | -395.24% | -395.24% | -395.4% | -1,225.39% | -667.59% | - |
| Earnings before Tax (EBT) | - | - | - | - | - | -32.43 | - |
| Net income | - | - | - | - | - | -32.33 | -4.109 |
| Net margin | - | - | - | - | - | -602.08% | -23.76% |
| EPS | - | - | - | - | -0.8700 | -0.6100 | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/26/21 | 4/26/22 | 3/31/22 | 3/31/22 | 8/31/22 | 3/28/23 | 8/31/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 67.2 | 167 | 116 | 88 | 91.8 | 22.8 | 76.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | -29.5 | -45.9 | -49.3 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -49.2% | -58% | -95.3% | - | - | - |
| ROA (Net income/ Total Assets) | - | - | -31% | -40.6% | - | - | - | - |
| Assets 1 | - | - | 236.3 | 196.9 | - | - | - | - |
| Book Value Per Share 2 | - | -5.380 | 2.870 | 1.530 | 1.510 | 1.150 | -0.0500 | 0.6500 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | 0.94 | 2.51 | 0.69 | - | - | - | - |
| Capex / Sales | - | 133.43% | 24.67% | 7.44% | - | - | - | - |
| Announcement Date | 9/22/20 | 3/31/21 | 3/31/22 | 3/28/23 | 3/29/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.55
USD
Average target price
5
USD
Spread / Average Target
+96.08%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +35.14% | 113M | |
| +9.74% | 115B | |
| +11.91% | 106B | |
| -2.50% | 21.96B | |
| -13.76% | 21.87B | |
| -5.29% | 19.21B | |
| -3.39% | 18.08B | |
| -38.57% | 17.71B | |
| +6.25% | 14.32B | |
| +34.55% | 12.42B |
- Stock Market
- Equities
- ADAG Stock
- Financials Adagene Inc.
